Platinum Industries has incorporated a wholly owned subsidiary namely ‘Rivadu Lifesciences’ on March 18, 2026. The new entity has been incorporated to carry on the business of pharmaceuticals and lifesciences, including the manufacture, formulation, processing, development, blending, compounding, packing, repacking, labeling, relabeling, filling, trading, import, export, stocking, distribution, marketing, sale and supply of: Active Pharmaceutical Ingredients (APIs); Pharmaceutical intermediates; Excipients and specialty chemicals; and Finished pharmaceutical formulations in all dosage forms including tablets, capsules, injectables, biologics, biosimilars, vaccines, ophthalmics, dermatologicals, inhalation products, transdermals, nutraceuticals and herbal products.

Earlier, the board of directors of the company at its meeting held on February 12, 2026, had inter alia, considered and approved the same.

Platinum Industries is a multi-product company engaged in the business of manufacturing stabilizers. Its business segment includes PVC stabilizers, CPVC additives and lubricants.